IP Library › Granted Patent US 12,076,213
Granted Patent B2
US 12,076,213 · App. 16/762,234 · Granted Sep 3, 2024

Multilayered primary contact wound dressing

Inventors: Alexander Waite (Cowling, GB); Katherine A. Bourdillon (Leeds, GB)
Assignee: KCI USA, Inc.
A61F13/01029A61F13/00063A61F13/01012A61F13/05A61L15/225A61L15/325A61L15/425A61L15/64A61F2013/00221A61L2300/104A61L2300/106A61L2300/206A61L2300/21A61L2300/232A61L2300/402A61L2300/404A61L2300/41A61L2430/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,076,213
App. No.
16/762,234
Granted
Sep 3, 2024
Kind
B2
Abstract

The wound dressing described herein can be used as a contact layer dressing. The wound dressing can be positioned between a wound bed and a secondary dressing. The wound dressing can include a layered construction. Each of the layers can include a bioresorbable sponge enclosed within a collagen-based film. The wound dressing can include a plurality of fluid channels that enable fluid flow from the wound bed toward the environment-face side of the wound dressing.

Claims (28)

1. A wound contact dressing comprising:

a first bioresorbable sponge configured to degrade over a first predetermined amount of time, the first bioresorbable sponge comprises a first plurality of fluid channels that cut through the first bioresorbable sponge;

a first collagen-based film substantially covering a first face of the first bioresorbable sponge and lining an internal wall of each of the first plurality of fluid channels;

a second bioresorbable sponge configured to degrade over a second predetermined amount of time, the second bioresorbable sponge comprises a second plurality of fluid channels that cut through the second bioresorbable sponge;

a second collagen-based film between the first bioresorbable sponge and the second bioresorbable sponge, the second collagen-based film substantially covering a first face of the second bioresorbable sponge and lining an internal wall of each of the second plurality of fluid channels; and

a third collagen-based film substantially covering a second face of the second bioresorbable sponge.

2. The wound contact dressing of claim 1 , wherein the first bioresorbable sponge and the second bioresorbable sponge comprise freeze-dried collagen.

3. The wound contact dressing of claim 1 , wherein the first bioresorbable sponge and the second bioresorbable sponge comprise about 55% collagen and about 45% oxidized regenerated cellulose by weight.

4. The wound contact dressing of claim 1 , wherein the first bioresorbable sponge and the second bioresorbable sponge comprises about 55% collagen, about 44% oxidized regenerated cellulose, and about 1% silver-ORC by weight.

5. The wound contact dressing of claim 1 , wherein the second collagen-based film substantially covers a second face of the first bioresorbable sponge.

6. The wound contact dressing of claim 1 , wherein the first collagen-based film, the second collagen-based film, and the third collagen-based film comprise at least one of a high-density collagen film or a cross-linked collagen film.

7. The wound contact dressing of claim 1 , wherein each of the first plurality of fluid channels and the second plurality of channels are configured to enable fluid flow from a wound site to a secondary dressing.

8. The wound contact dressing of claim 1 , wherein the first predetermined amount of time is different than the second predetermined amount of time.

9. The wound contact dressing of claim 1 , wherein the first bioresorbable sponge comprises a higher collagen density than the second bioresorbable sponge.

10. The wound contact dressing of claim 1 , wherein the first bioresorbable sponge is a wound facing layer and the second bioresorbable sponge is an environment facing layer.

11. The wound contact dressing of claim 10 , wherein the first bioresorbable sponge comprises an antimicrobial agent and the second bioresorbable sponge does not comprise the antimicrobial agent.

12. The wound contact dressing of claim 11 , wherein the second bioresorbable sponge comprises an anti-inflammatory agent.

13. The wound contact dressing of claim 1 , wherein the first bioresorbable sponge and the second bioresorbable sponge comprise at least one of an anti-oxidant or an analgesic.

14. The wound contact dressing of claim 1 , wherein the first bioresorbable sponge comprises at least one of polyhexamethylene biguanide, citric acid, silver, silver-ORC, or iodine.

15. The wound contact dressing of claim 1 , wherein the first collagen-based film, the second collagen-based film, and the third collagen-based film comprise a plasticizer.

16. The wound contact dressing of claim 1 , wherein the first collagen-based film, the second collagen-based film, and the third collagen-based film degrade over a third predetermined amount of time, wherein the third predetermined amount of time is greater than the first predetermined amount of time and the second predetermined amount of time.

17. The wound contact dressing of claim 1 , further comprising:

a non-resorbable backing layer coupled with the third collagen-based film.

18. The wound contact dressing of claim 1 , wherein the first bioresorbable sponge is enclosed by the first collagen-based film and the second collagen-based film, and wherein the second bioresorbable sponge is enclosed by the second collagen-based film and the third collagen-based film.

19. The wound contact dressing of claim 18 , wherein the first collagen-based film, the second collagen-based film, and the third collagen-based film form a barrier between both the first bioresorbable sponge and the second bioresorbable sponge and the external environment.

20. The wound contact dressing of claim 18 , wherein the first collagen-based film, the second collagen-based film, and the third collagen-based film are fused together at a laminated edge.

21. The wound contact dressing of claim 1 , wherein the first plurality of fluid channels are aligned with the second plurality of fluid channels.

22. The wound contact dressing of claim 1 , wherein the first bioresorbable sponge and the second bioresorbable sponge each comprise a porous structure, and wherein the first plurality of fluid channels perforate the porous structure of the first bioresorbable sponge and the second plurality of fluid channels perforate the porous structure of the second bioresorbable sponge.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2024
From: WAITE, ALEXANDER
To: KCI USA, INC.; SYSTAGENIX WOUND MANAGEMENT, LIMITED
Reel/Frame 068337/0873 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ADD THE SECOND ASSIGNEE PREVIOUSLY RECORDED AT REEL: 64500 FRAME: 66. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 30, 2024
From: BOURDILLON, KATIE
To: KCI USA, INC.; SYSTAGENIX WOUND MANAGEMENT, LIMITED
Reel/Frame 068192/0846 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2023
From: BOURDILLON, KATHERINE A.
To: KCI LICENSING, INC.
Reel/Frame 064500/0066 →
Continuity (2)
Provisional Application 62584010 · Nov 9, 2017
Related Publication 20200345557A1 · Nov 5, 2020